Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions

By Douet-Guilbert Nathalie  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 537-544

Springer Publishing Company

Access to resources Recommend Favorite

Myelodysplastic syndromes: molecular pathogenesis and genomic changes

By Nolte Florian  

Annals of Hematology, Vol. 87, Iss. 10, 2008-10 ,pp. : 777-795

Springer Publishing Company

Access to resources Recommend Favorite

The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessment

By Bennett John   Komrokji Rami  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 258-269

Maney Publishing

Access to resources Recommend Favorite

Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics

By Trost D.   Hildebrandt B.   Muller N.   Germing U.   Royer-Pokora B.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

Iron overload and myelodysplastic syndromes.

By Rose C.   Cambier N.   Mahieu M.   Ernst O.   Fenaux P.  

Transfusion Clinique et Biologique, Vol. 8, Iss. 5, 2001-10 ,pp. : 422-432

Elsevier

Access to resources Recommend Favorite